Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1982 1
1983 4
1988 1
1989 1
1990 1
1991 2
1992 1
1993 1
1994 1
1995 4
1996 1
1997 3
1998 2
1999 4
2000 3
2001 7
2002 10
2003 8
2004 12
2005 8
2006 13
2007 8
2008 4
2009 15
2010 15
2011 15
2012 16
2013 25
2014 26
2015 48
2016 46
2017 35
2018 37
2019 38
2020 40
2021 60
2022 51
2023 64
2024 32

Text availability

Article attribute

Article type

Publication date

Search Results

575 results

Results by year

Filters applied: . Clear all
Page 1
Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update.
Levy ML, Bacharier LB, Bateman E, Boulet LP, Brightling C, Buhl R, Brusselle G, Cruz AA, Drazen JM, Duijts L, Fleming L, Inoue H, Ko FWS, Krishnan JA, Mortimer K, Pitrez PM, Sheikh A, Yorgancıoğlu A, Reddel HK. Levy ML, et al. NPJ Prim Care Respir Med. 2023 Feb 8;33(1):7. doi: 10.1038/s41533-023-00330-1. NPJ Prim Care Respir Med. 2023. PMID: 36754956 Free PMC article. Review.
For patients with moderate-severe asthma, the preferred regimen is maintenance-and-reliever therapy (MART) with ICS-formoterol. Asthma treatment is not "one size fits all"; GINA recommends individualized assessment, adjustment, and review of treatment. ...
For patients with moderate-severe asthma, the preferred regimen is maintenance-and-reliever therapy (MART) with ICS-formoterol. Asthm …
Reply to G. Escalante and D. St. Mart.
Askow AT, Burd NA. Askow AT, et al. Int J Sport Nutr Exerc Metab. 2023 Feb 22;33(3):173. doi: 10.1123/ijsnem.2023-0010. Print 2023 May 1. Int J Sport Nutr Exerc Metab. 2023. PMID: 36812921 Free article. No abstract available.
1alpha,25(OH)(2)D(3) Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Metastasis After VEGF-A Stimulation.
Chiang KC, Yeh CN, Pang JS, Hsu JT, Yeh TS, Chen LW, Kuo SF, Takano M, Chen TC, Kittaka A, Hsieh PJ, Juang HH. Chiang KC, et al. Anticancer Res. 2017 Nov;37(11):6215-6221. doi: 10.21873/anticanres.12072. Anticancer Res. 2017. PMID: 29061804
During this process, expression of snail family transcriptional repressor 1 and 2, and fibronectin was up-regulated. 1alpha,25(OH)(2)D(3) and MART-10 counteracted VEGF-A-induced EMT. In addition, expression of neuropilin 1, a key protein in VEGF-A signaling, was dow …
During this process, expression of snail family transcriptional repressor 1 and 2, and fibronectin was up-regulated. 1alpha,25(OH)(2)D …
MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma.
Chiang KC, Yeh TS, Huang CC, Chang YC, Juang HH, Cheng CT, Pang JS, Hsu JT, Takano M, Chen TC, Kittaka A, Hsiao M, Yeh CN. Chiang KC, et al. Sci Rep. 2017 Mar 3;7:43773. doi: 10.1038/srep43773. Sci Rep. 2017. PMID: 28256614 Free PMC article.
In this study, we demonstrated that both the 1alpha,25(OH)(2)D(3) analog, MART-10, and 1alpha,25(OH)(2)D(3) possessed anti-growth effect on human CCA cells with MART-10 much more potent than 1alpha,25(OH)(2)D(3). ...Vitamin D receptor (VD …
In this study, we demonstrated that both the 1alpha,25(OH)(2)D(3) analog, MART-10, and 1alpha,25(OH)(2)D(3) possessed a …
Identification and quantification of phytochemicals of Chamaecostus cuspidatus (Nees & Mart.) C.D.Specht & D.W.Stev and Cheilocostus speciosus (J. Koenig) C.D.Specht by LC-MS techniques and their in-vitro anti-adipogenic screening.
Shukla V, Bajpai V, Singh P, Rai P, Khandelwal N, Gaikwad AN, Singh B, Kumar B. Shukla V, et al. Nat Prod Res. 2023 Jul;37(14):2461-2465. doi: 10.1080/14786419.2022.2050225. Epub 2022 Mar 12. Nat Prod Res. 2023. PMID: 35285353
Chamaecostus cuspidatus (Nees & Mart.) C.D.Specht & D.W.Stev and Cheilocostus speciosus (J.Koenig) C.D.Specht contain bioactive compounds that possess many pharmacological activities including antidiabetic and hypolipidemic. ...
Chamaecostus cuspidatus (Nees & Mart.) C.D.Specht & D.W.Stev and Cheilocostus speciosus (J.Koenig) C.D.S …
MART-10, a 1alpha,25(OH)(2)D(3) Analog, Potently Represses Metastasis of ER(+) Breast Cancer Cells with VEGF-A Overexpression.
Chiang KC, Yeh CN, Yeh TS, Juang HH, Chen LW, Kuo SF, Chen MH, Chen TC, Takano M, Kittaka A, Pang JS. Chiang KC, et al. Anticancer Res. 2018 Jul;38(7):3879-3887. doi: 10.21873/anticanres.12672. Anticancer Res. 2018. PMID: 29970508
In addition to inducing angiogenesis, vascular endothelial growth factor-A (VEGF-A) is believed to directly increase cancer cell metastatic potential and overexpression of VEGF-A is associated with higher invasiveness of breast cancer. 1alpha,25(OH)(2)D(3), the active form …
In addition to inducing angiogenesis, vascular endothelial growth factor-A (VEGF-A) is believed to directly increase cancer cell metastatic …
MART-10, a New Generation of Vitamin D Analog, Is More Potent than 1alpha,25-Dihydroxyvitamin D(3) in Inhibiting Cell Proliferation and Inducing Apoptosis in ER+ MCF-7 Breast Cancer Cells.
Chiang KC, Yeh CN, Chen SC, Shen SC, Hsu JT, Yeh TS, Pang JH, Su LJ, Takano M, Kittaka A, Juang HH, Chen TC. Chiang KC, et al. Evid Based Complement Alternat Med. 2012;2012:310872. doi: 10.1155/2012/310872. Epub 2012 Dec 11. Evid Based Complement Alternat Med. 2012. PMID: 23304196 Free PMC article.
Therefore, we investigated the effects of a less-calcemic 1alpha,25(OH)(2)D(3) analog, 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D(3 )(MART-10), on ER+MCF-7 cells. We demonstrate that MART-10 is 500- to 1000-fold more potent than 1alph …
Therefore, we investigated the effects of a less-calcemic 1alpha,25(OH)(2)D(3) analog, 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihy …
MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential.
Chiang KC, Kuo SF, Chen CH, Ng S, Lin SF, Yeh CN, Chen LW, Takano M, Chen TC, Juang HH, Kittaka A, Lin JD, Pang JH. Chiang KC, et al. Cancer Lett. 2015 Dec 1;369(1):76-85. doi: 10.1016/j.canlet.2015.07.024. Epub 2015 Aug 14. Cancer Lett. 2015. PMID: 26282787
The active form of vitamin D3, 1alpha,25(OH)2D3, has been shown to have a anti-metastatic effect in pre-clinical studies, however induction of hypercalcemia hampered its clinical application. The new class of less-calcemic vitamin D analog, 19-nor-2alpha-(3-hydroxypropyl)- …
The active form of vitamin D3, 1alpha,25(OH)2D3, has been shown to have a anti-metastatic effect in pre-clinical studies, however induction …
The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential.
Chiang KC, Yeh TS, Chen SC, Pang JH, Yeh CN, Hsu JT, Chen LW, Kuo SF, Takano M, Kittaka A, Chen TC, Sun CC, Juang HH. Chiang KC, et al. Int J Mol Sci. 2016 Apr 21;17(4):606. doi: 10.3390/ijms17040606. Int J Mol Sci. 2016. PMID: 27110769 Free PMC article.
In this study, we demonstrated that both 1alpha,25(OH)2D3 and MART-10 could effectively repress TNBC cells migration and invasion with MART-10 more effective. ...LCN2, one kind of breast cancer metastasis stimulator, was also found for the first time to be repressed …
In this study, we demonstrated that both 1alpha,25(OH)2D3 and MART-10 could effectively repress TNBC cells migration and invasion wit …
575 results